BioRem Inc. (CVE:BRM – Get Free Report) hit a new 52-week high during trading on Thursday. The stock traded as high as C$4.46 and last traded at C$4.27, with a volume of 25,080 shares. The stock had previously closed at C$4.44.
BioRem Price Performance
The company has a debt-to-equity ratio of 14.17, a quick ratio of 1.08 and a current ratio of 2.04. The firm has a market capitalization of C$70.01 million, a price-to-earnings ratio of 12.86 and a beta of 0.77. The business has a fifty day moving average of C$3.60 and a two-hundred day moving average of C$3.12.
Insider Buying and Selling
In other BioRem news, Director Derek Webb sold 28,700 shares of BioRem stock in a transaction on Monday, August 24th. The shares were sold at an average price of C$3.82, for a total transaction of C$109,634.00. Following the completion of the transaction, the director directly owned 362,370 shares of the company’s stock, valued at C$1,384,253.40. The trade was a 7.34% decrease in their ownership of the stock. 1.90% of the stock is currently owned by company insiders.
BioRem Company Profile
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.
Further Reading
- Five stocks we like better than BioRem
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
